Clinical studies recruiting near Akita

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase 3 · Akita University Hospital ( Site 3207) · Merck Sharp & Dohme LLC · NCT07060807 A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resist
Phase 3 · Akita University Hospital ( Site 0728) · Merck Sharp & Dohme LLC · NCT06136650 Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06659393 A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/S
Phase 1 · Akita University Hospital · Ono Pharmaceutical Co., Ltd. · NCT06547528 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Akita University Hospital · Pfizer · NCT05020236 A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH
Phase 3 · Akita University Hospital - Dept of Obstetrics/Gynecology · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of M · NCT07340827 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Akita University Hospital ( Site 0904) · Merck Sharp & Dohme LLC · NCT06136624 A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 · Akita University Hospital ( Site 2302) · Merck Sharp & Dohme LLC · NCT06966700 Software as a Medical Device for the Treatment of Patients With PTSD
Phase 2/Phase 3 · Heart Care Clinic Omachi · Otsuka Medical Devices Co., Ltd. Japan · NCT06589505 Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Phase N/A · Research Site · AstraZeneca · NCT05454787 Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · Akita University Hospital · Eli Lilly and Company · NCT07157774 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Akita City Hospital · AgNovos Healthcare, LLC · NCT04796350 Special Drug Use-results Surveillance of Tafinlar/Mekinist
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06262919 A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
Phase 2 · Akita Prefectural Center For Rehabilitation and Psychiatric · Ono Pharmaceutical Co., Ltd. · NCT06803823 Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausa
Phase 3 · Akita University Hospita · Tokyo Women's Medical University · NCT07671885 A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN,
Phase N/A · argenx · NCT06078553 A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRN
Phase 1/Phase 2 · ModernaTX, Inc. · NCT05130437 ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
Phase 1 · Akita University Hospital · Enliven Therapeutics · NCT06787144 A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in
Phase 3 · Akita University Hospital ( Site 5115) · Merck Sharp & Dohme LLC · NCT06841354 A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Phase 3 · Amgen · NCT06747949 Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Car
Phase 3 · Research Site · Arcus Biosciences, Inc. · NCT07011719

Look up another city

Look up another condition